Astral Systems secured a €26 million Series A to support commercialisation of medical isotopes.
- Amount
- $29.6M
- Stage
- Series A
- Announced
- 23 June 2026
- Use of funds
- Support medical isotope commercialisation
- Checked
- Amount and date matched across 2 press sources